Valuation

Newamsterdam Pharma Company N.v. Valuation

Valuation for Newamsterdam Pharma Company N.v. (NAMS) on 6ix covers company data, market context, news, risks, and AI research briefs.

websiteNAMSValuation/analysis/NAMS/valuation

Newamsterdam Pharma Company N.v.

Newamsterdam Pharma Company N.v. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to NAMS.

Stock profile

Ticker

NAMS

Asset type

Stock

Market cap

$3.55B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Newamsterdam Pharma Company N.v. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • NAMS primary listing
  • KH6
  • A3DUAC

Research sections

Valuation

Review valuation context for Newamsterdam Pharma Company N.v..

Future growth

Review future growth context for Newamsterdam Pharma Company N.v..

Past performance

Review past performance context for Newamsterdam Pharma Company N.v..

Financial health

Review financial health context for Newamsterdam Pharma Company N.v..

Dividend

Review dividend context for Newamsterdam Pharma Company N.v..

Management

Review management context for Newamsterdam Pharma Company N.v..

Ownership

Review ownership context for Newamsterdam Pharma Company N.v..

Other information

Review other information context for Newamsterdam Pharma Company N.v..

Community

Review community context for Newamsterdam Pharma Company N.v..